WILMINGTON, DE — NRx Pharmaceuticals Inc. (Nasdaq: NRXP) has begun commercial sales operations for its newly approved, U.S.-manufactured preservative-free ketamine injection, targeting a pharmaceutical market affected by supply…

WILMINGTON, DE — NRx Pharmaceuticals Inc. (Nasdaq: NRXP) has begun commercial sales operations for its newly approved, U.S.-manufactured preservative-free ketamine injection, targeting a pharmaceutical market affected by supply shortages since …

Source disclosure

This is a source-linked briefing. Read the original report from Mychesco .